ART OF MEDICINE 2017

 

PECULIARITIES OF THE DISTRIBUTION AND DYNAMICS OF EXPRESSION OF APOPTOSIS MARKER Bax IN PACTIENTS WITH RECTAL CANCER UNDER THE INFLUENCE OF NEOADJUVANT CHEMORADIOTHERAPY WITH THE USAGE OF NITRIC OXIDE PRECURSOR

 

V.V. Golotiuk, S.I.Golotiuk, I.S.Golotiuk, A.E. Kryzhanivska, S.S. Goroshko

          SHEI «Ivano-Frankivsk National Medical University», Ivano-Frankivsk, Ukraine.

 

Abstract

Abstract. The aim of research is to determine the peculiarities of proapoptotic Bax protein expression in the intact intestine and tumor of patients with rectal cancer under the influence of neoadjuvant chemoradiotherapy (NCRT) using polyradiomodification with ftorafur and tivortine. Bax expression was determined by immunohistochemistry in biopsy and surgical material before and after NCRT in 21 patients with adenocarcinoma of the rectum stage II-III. It has been established that under the influence of NCRT the level of Bax expression in the intact rectum increases slightly. However, expression of Bax in residual tumor parenchyma has increased greatly compared with thаt before treatment, especially after polyradiomodification, thus correlating with the degree of therapeutic pathomorphosis. This indicates the importance of the apoptosis as a mechanism of NCRT antineoplastic action, as well as the feasibility of the polyradiomodification with the usage of nitric oxide precursor.

 

Key words: rectal cancer, apoptosis, chemoradiotherapy, therapeutical pathomorphosis, nitric oxide.

 

Full text: PDF (Rus)

References
  1. Impact of proapoptotic proteins Bax and Bak in tumor progression and response to treatment./ P.F.Cartron, P. Juin, L. Oliver [et al.] // Expert Rev Anticancer Ther. – 2003. – Vol. 3, 4. – P. 563-570.
  2. Hector S. Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer: a review. / Hector, J.H. Prehn // Biochim Biophys Acta. – 2009. –  Vol.1795, N. 2. – P.117-129.
  3. Bax protein may influence the invasion of colorectal cancer / A. Pryczynicz, M. Gryko, K. Niewiarowska [et al.] // World Journal of Gastroenterology. – – Vol. 20, N. 5. – P. 1305-1310.
  4. Фильченков А.А. Визуализация и оценка апоптоза, вызванного противоопухолевой терапией: клинические перспективы / А.А. Фильченков // Онкология. – – Т. 13, № 4. –С. 266-277.
  5. Brunelle J.K. Control of mitochondrial apoptosis by the Bcl-2 family / J.K.Brunelle, A.  Letai // J Cell Sci. – – Vol. 122. – P. 437-441.
  6. Effects of chemokines on proliferation and apoptosis of human mesangial cells / M. Wornle, H. Schmid, M. Merkle [et al.] // BMC Nephrol. – 2004. – Vol. 5. – 8.
  7. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway / M. De Ridder,  G. Van Esch,  B. Engels [et al.] // Bull Cancer. – – Vol. 95, N. 3. – P. 282-291.
  8. Yasuda H. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: Novel strategy for cancer therapy: Nitric oxide donor as a therapeutic enhancer / H. Yasuda // Nitric Oxide. – – Vol. 19, N. 2. – P. 205-216.
  9. Singh S. Mini review nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies / S. Singh, A.K. Gupta // Cancer Chemother Pharmacol. – – Vol. 67, N. 6. – P. 1211–1224.
  10. Therapeutic potential of nitric oxide-modified drugs in colon cancer cells / M.Mojic, S. Mijatovic, D. Maksimovic-Ivanic [et al.] // Mol Pharmacol. – – Vol. 82, N. 4. – P. 700-710.